article thumbnail

?5 Things You Need to Know from Our Recent Gene Therapy Webinar

Worldwide Clinical Trials

We’ve also seen a decrease in available research nurses, as they have had to be reassigned to COVID patients. These therapies can have mechanisms that could expose people to biological or biohazardous agents, so therapies must be closely monitored and contained during transport, storage, and administration.